New Class of Drugs for TBI

Alzheimer's disease therapeutic prevents long-term damage from TBI in pre-clinical studies 03/15/09. A class of Alzheimer's disease drugs currently studied in clinical trials appears to reduce damage caused by traumatic brain injury in animals, researchers at Georgetown University Medical Center report in an upcoming advance online publication of Nature Medicine. Georgetown University Medical Center via Eurekalert!